Baersch G, Baumann M, Ritter J, Jürgens H, Vormoor J
Department of Paediatric Haematology/Oncology, University of Münster, Germany.
Br J Haematol. 1999 Dec;107(3):572-80. doi: 10.1046/j.1365-2141.1999.01746.x.
To identify residual candidate normal progenitor/stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia (ALL), expression of AC133 and CD117 was analysed on the leukaemic cell clone and on immature B-lineage-negative CD34+CD19- bone marrow cells. 10/25 patients (40%) had no detectable expression of AC133 within the leukaemic cell clone. 24/26 patients (92%) lacked expression of CD117 on the leukaemic blast cell population. In contrast, a distinct AC133-positive cell population was found in 8/8 children with AC133-negative ALL and a CD117-positive cell population could be identified in 12/12 children with CD117-negative ALL, within the CD34+CD19- progenitor/stem cell compartment. These observations provide further evidence that in B-cell precursor ALL, unlike in acute myelogenous leukaemia, it may be possible to distinguish residual normal progenitor/stem cells from the leukaemic cell clone.
为了识别儿童B细胞前体急性淋巴细胞白血病(ALL)中残留的候选正常祖细胞/干细胞群体,我们分析了白血病细胞克隆以及未成熟B谱系阴性的CD34+CD19-骨髓细胞上AC133和CD117的表达情况。25例患者中有10例(40%)白血病细胞克隆内未检测到AC133表达。26例患者中有24例(92%)白血病原始细胞群体缺乏CD117表达。相反,在CD34+CD19-祖细胞/干细胞区室中,8例AC133阴性ALL儿童中有8例发现了明显的AC133阳性细胞群体,12例CD117阴性ALL儿童中有12例可识别出CD117阳性细胞群体。这些观察结果进一步证明,在B细胞前体ALL中,与急性髓细胞白血病不同,有可能将残留的正常祖细胞/干细胞与白血病细胞克隆区分开来。